Rajeev Sehgal, DPM
Podiatrist · Clarkston, MINPI 1184723413
Payments from drug & device makers
Across 56 payments — averaging $74.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$2K
- Biopro, Inc.$701
- Smith+Nephew$619
- Stryker$154
- Zimmer Biomet$143
- Paragon 28, Inc.$140
- plus $826 from 15 others
What the payments were for
- Consulting fees$60014%
- Speaking & faculty fees$1,50036%
- Food & beverage$2,01448%
- Education$491%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 5 | $1,580 |
| Biopro, Inc. | 4 | $701 |
| Smith+Nephew | 14 | $619 |
| Stryker(2 entities) | 5 | $154 |
| Zimmer Biomet | 2 | $143 |
| Paragon 28, Inc. | 8 | $140 |
| Organogenesis Inc. | 1 | $133 |
| Integra Lifesciences Corporation | 2 | $121 |
| KCI USA, Inc. | 1 | $117 |
| Linvatec Corporation | 1 | $114 |
| Johnson & Johnson | 1 | $92 |
| Kerecis Limited | 2 | $69 |
| AbbVie | 1 | $28 |
| Nevro Corp. | 1 | $28 |
| Bioventus LLC | 2 | $27 |
| Mimedx Group, Inc. | 1 | $21 |
| Orthofix Medical, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Pinnacle, Inc | 1 | $15 |
| Aroa Biosurgery Incorporated | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Extremilock Foot$1,500
- EXT-ExtremiLock Ankle$1,500
- EXT-Hemi$1,500
- EXT-Staple$1,500
- STRAVIX PL$266
- Stravix$146
- Grafix$146
- GRAFIX PL$146
- PuraPly$133
- SCP Bone Substitute$118
- VAC ULTA$117
- NeoSpan$114
- BioBrace 23mm$114
How this compares
$4,163 in reported general payments places this provider in the 75th percentile of 302 podiatrist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 43 | $993 |
| Gabapentin | 26 | $376 |
| Methylprednisolone | 43 | $270 |
| Naproxen | 37 | $253 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $134 |
| Levofloxacin | 13 | $107 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $94 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Clarkston
- Fadi JaafarAlma$191K
- Jeffrey KleinLivonia$117K
- Gary RothenbergAnn Arbor$85K
- Randy SemmaCommerce Twp$31K
- Alton JohnsonAnn Arbor$21K
- Krista KotzevaSouthfield$20K
- Darryl MartinsJackson$19K
- Hassan AlkhalilDearborn$18K
- Joshua KazdanSouthfield$18K
- Daniel AronovitzWarren$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.